Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Current Directions in Biomedical Engineering

Joint Journal of the German Society for Biomedical Engineering in VDE and the Austrian and Swiss Societies for Biomedical Engineering

Editor-in-Chief: Dössel, Olaf

Editorial Board: Augat, Peter / Buzug, Thorsten M. / Haueisen, Jens / Jockenhoevel, Stefan / Knaup-Gregori, Petra / Kraft, Marc / Lenarz, Thomas / Leonhardt, Steffen / Malberg, Hagen / Penzel, Thomas / Plank, Gernot / Radermacher, Klaus M. / Schkommodau, Erik / Stieglitz, Thomas / Urban, Gerald A.

Open Access
See all formats and pricing
More options …

Quantification method for timolol from in vivo samples for the development of a new glaucoma drug depot

Thomas Eickner / Franziska Kopp / Andreas Brietzke / Sabine Kischkel / Stefan Oschatz / Klaus-Peter Schmitz
  • University Medical Center Rostock, Institute for Biomedical Engineering, Rostock, Germany and Institute for Implant Technology and Biomaterials e.V., Rostock, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rudolf Guthoff / Niels Grabow
Published Online: 2018-09-22 | DOI: https://doi.org/10.1515/cdbme-2018-0055


Glaucoma is the second most common cause of blindness. An increased intraocular pressure is the only treatable symptom of glaucoma. Because patients often exhibit a poor therapy adherence, a drug depot consisting of ELA-NCO and hyaluronic acid with timolol was developed to ensure sustained drug release. This drug depot is formed by in situ polymerisation after injection into the subconjunctival space. To test the in vivo drug release of timolol in serum and aqueous humour, a liquid chromatography mass spectrometry (LCMS) method was developed and tested using spike- and recovery experiments, and on in vivo samples after topical application. Samples of serum and aqueous humour were taken from New Zealand White rabbits. For topical application, a commercially available formulation of timolol was used. This study presents results concerning the recovery of timolol from spiked samples. Serum and aqueous humour samples were spiked with timolol maleate to a final concentration of 50 ng/mL. Subsequently, the samples were extracted and analysed by LCMS. External calibration of the developed method showed high linearity. Recovery experiments showed no loss of timolol. Hence, the extraction method is robust and able to recover the whole amount of timolol from aqueous humour and serum.

Keywords: glaucoma; liquid chromatography mass spectrometry; drug delivery; timolol; in situ polymerization

About the article

Published Online: 2018-09-22

Published in Print: 2018-09-01

Citation Information: Current Directions in Biomedical Engineering, Volume 4, Issue 1, Pages 225–227, ISSN (Online) 2364-5504, DOI: https://doi.org/10.1515/cdbme-2018-0055.

Export Citation

© 2018 by Walter de Gruyter Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in